Tainá M. Marques

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

Tainá M. Marques, Anouke van Rumund, Patrick Oeckl et al. · Neurology · 2019 · 147 citations · Full text

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy

Tainá M. Marques, H. Bea Kuiperij, Ilona B. Bruinsma et al. · Molecular Neurobiology · 2016 · 135 citations · Full text

Multiple System Atrophy, Neurological Progress, Neurochemical Biomarkers +20

Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion

Patrick Oeckl, Sarah Anderl‐Straub, Christine A. F. Von Arnim et al. · Journal of Neurology Neurosurgery & Psychiatry · 2022 · 91 citations

Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy

Anna M. de Kort, H. Bea Kuiperij, Tainá M. Marques et al. · Annals of Neurology · 2023 · 45 citations · Full text

Early-to-mid stage idiopathic Parkinson’s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females

Christophe Capelle, Séverine Ciré, Fanny Hedin et al. · Nature Communications · 2023 · 32 citations · Full text